Tashatuvango / shutterstock.com
The US Food and Drug Administration has awarded 21 new clinical trial research grants totalling more than $23 million in order to boost the development of products for patients with rare diseases.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
FDA, rare disease, grants, Orphan Products Clinical Trial Grants Program, research and development
